aspartic acid has been researched along with naltrindole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lisi, TL; Sluka, KA; Vance, CG | 1 |
| Kayashima, S; Nagase, H; Oka, JI; Saitoh, A; Soda, A; Yamada, M; Yoshizawa, K | 1 |
2 other study(ies) available for aspartic acid and naltrindole
| Article | Year |
|---|---|
High-frequency, but not low-frequency, transcutaneous electrical nerve stimulation reduces aspartate and glutamate release in the spinal cord dorsal horn.
Topics: Animals; Arthritis, Experimental; Aspartic Acid; Carrageenan; Chromatography, High Pressure Liquid; Glutamic Acid; Joints; Microdialysis; Naltrexone; Narcotic Antagonists; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Transcutaneous Electric Nerve Stimulation | 2005 |
A delta opioid receptor agonist, KNT-127, in the prelimbic medial prefrontal cortex attenuates glial glutamate transporter blocker-induced anxiety-like behavior in mice.
Topics: Amino Acid Transport System X-AG; Animals; Anti-Anxiety Agents; Anxiety; Aspartic Acid; Drug Interactions; gamma-Aminobutyric Acid; Glutamic Acid; Male; Mice; Microinjections; Morphinans; Naltrexone; Prefrontal Cortex; Receptors, Opioid, delta | 2018 |